Healthcare Providers and Services
Company Overview of Labco S.A.S.
Labco S.A.S., a medical diagnostics company, owns and operates a pan-European network of local and regional clinical laboratories. Its laboratories provide physicians and patients with a portfolio of tests in clinical chemistry, hematology, immunology, microbiology, parasitology, pathology, serology, toxicology, virology, genetic testing, and other fields. The company, through a joint venture, also offers laboratory outsourcing services to hospitals and other healthcare organizations in the United Kingdom. Labco S.A.S. was founded in 2003 and is based in Paris, France. It has laboratory locations in France, Spain, Portugal, Germany, Belgium, Italy, and the Netherlands. The company also has o...
60-62, rue d'Hauteville
Founded in 2003
Key Executives for Labco S.A.S.
Co-Founder and Vice President of France
Group Chief Information Officer and Vice President of Organization & Information Technology
Vice President of Marketing & Sales and Head of European Development
Compensation as of Fiscal Year 2014.
Labco S.A.S. Key Developments
Labco S.A.S. Presents at Bank of America Merrill Lynch European High-Yield Healthcare Conference, May-21-2014 10:00 AM
Apr 1 14
Labco S.A.S. Presents at Bank of America Merrill Lynch European High-Yield Healthcare Conference, May-21-2014 10:00 AM. Venue: Connaught Hotel, London, United Kingdom. Speakers: Vincent Marcel, Chief Financial Officer.
Labco S.A.S. Changes Corporate Form of the Issuer
Feb 19 13
On January 12, 2012, Labco S.A.S., a private limited liability company (société par actions simplifiée) converted its corporate form into a société anonyme. References to Labco S.A.S. in the name of the Issuer have now changed to Labco S.A.
Labco S.A Raises EUR 100 Million in Private Placement of Senior Notes
Feb 18 13
Labco S.A., has completed a private placement of EUR 100 million in aggregate principal amount of its 8.5% senior secured notes due 2018. Kirkland & Ellis International LLP acted as legal advisor to the company. The notes constitute a further issuance of, and will form a single class with, Labco's existing 8.5% senior secured notes due 2018. The notes are being offered only to qualified institutional buyers and will mature on January 15, 2018.
Similar Private Companies By Industry
Recent Private Companies Transactions